The EPIC-InterAct study received funding from the European Union (Integrated Project LSHM-CT-2006-037197 in the Framework Programme 6 of the European Community). We thank all EPIC participants and staff for their contribution to the study. We thank Nicola Kerrison (MRC Epidemiology Unit, University of Cambridge, Cambridge, UK) for managing the data...
Review on t(14;16)(q32;q23) IGH/MAF, with data on clinics, and the genes involved.
Review on t(14;16)(q32;q23) IGH/MAF, with data on clinics, and the genes involved.
Review on t(14;16)(q32;q23) IGH/MAF, with data on clinics, and the genes involved.
This work was supported by a Sabbatical programme awarded to Ching SM by Universiti Putra Malaysia. European Prospective Investigation into Cancer–Norfolk is funded by grants from the Medical Research Council UK (G9502233, G0401527) and Cancer Research UK (C864/A8257, C864/A2883). We further acknowledge core MRC Epidemiology Unit support through Pr...
The EPIC-Norfolk study is supported by programme grants from the Medical Research CouncilandCancer Research UKwith additional support from the Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, and the Wellcome Trust. Alexander Mok was supported by the National Science Scholarship from Singapore, A*STAR (Agen...
